There are models that endure because they work, and models that endure because no one wants to question them too loudly. The Hub-and-Spoke structure in medical device marketing sits somewhere in between — an elegant diagram with a long shadow. It promises coherence. It promises efficiency. It promises that strategy can be held in one hand while relevance is executed in the other. In theory, it bridges continents and cultures. In practice, it often exposes how fragile our assumptions about alignment truly are. The tension begins with an uncomfortable truth: the medical device industry does not reward structural purity. It rewards clinical credibility, speed of adoption, and the subtle choreography between evidence, regulation, and human behavior. No organizational chart can fully contain that complexity — yet the Hub-and-Spoke model claims it can. Perhaps that is why its appeal is so enduring. It simplifies a world that resists simplification.

  Global teams cling to the promise of consistency.
  Regional teams cling to the promise of relevance.

Both sides cling to the model as if it is the agreement that keeps everything from dissolving.

The irony is that the diagram is the easy part. The hard part is everything that happens inside it. The Hub-and-Spoke model works beautifully on the whiteboard. A central hub holds the clinical narrative, the regulatory truth, the brand’s essence. Around it, local teams interpret this truth through the lens of their clinicians, their healthcare systems, their reimbursement landscapes. It should be symphonic: one theme, many expressions. This is the ideal. An elegant network where strategy and reality speak to each other like equals. But this ideal unravels quickly the moment either side forgets its role. When global strategy becomes doctrine rather than intelligence, the centre hardens. The Hub begins to speak in declarations instead of hypotheses. It edits rather than listens. It protects the story rather than explores whether the story survives contact with the field. And in that moment, the Spokes stop being extensions of insight and become mere recipients of content they must “implement,” often with the quiet knowledge that the material will not land as intended.

The reverse is equally corrosive. Regional teams sometimes turn the model into a dependency loop — a constant outsourcing of thought under the comforting illusion that “global owns strategy.” They wait for direction, wait for collateral, wait for decisions, wait for validation. The Hub becomes a production line, drowning in requests it cannot possibly satisfy. The Spokes become frustrated by their own inertia. And the relationship curdles into a pattern of escalations and apologies. Neither side intends this, yet both contribute to it.  Because the Hub-and-Spoke model, for all its beauty, contains an intrinsic flaw: it assumes maturity, capability, and cultural intelligence on both ends of the wheel.

In organizations where these qualities exist, the model becomes almost invisible. Teams operate with a kind of confident interdependence. Global teams share not just the “what,” but the thinking behind it. Regional teams contribute not just the “feedback,” but the patterns behind the feedback. There is an adult-to-adult quality in the exchange — the kind of relationship that produces speed, trust, and clarity.  But in organizations where maturity is uneven — where roles were inherited rather than designed, where marketing capability varies widely across regions, where historical grievances distort communication — the model becomes a stage where insecurities are performed rather than solved. The diagram remains elegant. The behavior inside it becomes anything but.

And this is where the medical device industry reveals its deeper fault line. It is not the structure that determines performance — it is the ability of the people inside the structure to tolerate contradiction. Medical marketing is full of contradiction. Evidence must be precise, yet messaging must be compelling. Strategy must be global, yet execution must be local. Regulations must be respected, yet offers must be competitive. Every part of the work requires a balance between constraint and creativity. The Hub-and-Spoke model was never designed to eliminate contradiction. It was designed to hold it. Yet many teams see contradiction as conflict rather than complexity — and that subtle misinterpretation destabilizes the entire system.

When the Hub assumes that strategy is sacred, it stops evolving.

When the Spoke assumes that local nuances invalidate global direction, it stops listening.

And when both assume their frustrations are unique, they stop being curious.

Curiosity — not structure — is what keeps the model alive.

A global marketer who asks, “How does this land in your market?” invites truth. A regional marketer who asks, “What is the strategic intent behind this?” invites partnership. A team that can say, “We are misaligned; let’s recalibrate,” creates a future. A team that says nothing creates distance. The companies that master the model understand something else as well: capability is not a side project. It is the fuel. Global teams need the capability to think beyond their own geography. Regional teams need the capability to adapt messaging without diluting it. Both sides need the capability to communicate with clarity, precision, and emotional maturity. When capability is uneven, the model becomes a hierarchy in disguise. One side infantilizes; the other side performs compliance. Real collaboration disappears under a fog of polite exchanges. And this is the pivotal insight: The Hub-and-Spoke model does not fail because it is wrong. It fails because it is easy to perform and difficult to inhabit.

It asks for clarity where organizations prefer ambiguity.

It asks for discipline where teams prefer improvisation.

It asks for truth where people prefer comfort.

It asks for shared identity where history has produced fragmentation.

It asks for partnership where habit has produced dependency.

It asks, ultimately, for a level of collective maturity that many organizations aspire to — but have never deliberately built.

Yet when the model works, it works in a way that feels almost effortless. The wheel turns. Information flows. Launches feel orchestrated rather than improvised. Clinicians receive consistent, credible messages. Sales teams feel supported. Regions feel heard. Global teams feel trusted. The company feels aligned. And perhaps that is why the model persists. Because even though it is difficult to execute well, it is still the most coherent way to hold together a global portfolio, a fragmented set of markets, and a demanding commercial environment.  But no team should mistake survival for success. A Hub-and-Spoke model that merely exists is not enough. The real question is whether it breathes.

A structure breathes when purpose is shared, when communication is honest, when decision rights are explicit, when capability is grown, and when both global and regional teams understand that their perspectives are incomplete without the other. A structure suffocates when the diagram replaces dialogue. The future of medical device marketing will not be determined by the elegance of our models, but by the intelligence and integrity with which we operate inside them. The Hub-and-Spoke system is not outdated — it is simply unforgiving. It amplifies whatever is already present: strength, weakness, trust, dysfunction, clarity, or confusion. In the right hands, it becomes an engine of coherence and adoption. In the wrong hands, it becomes a stalemate. The difference is not structural. It is human.

And that, perhaps, is the most honest critique: We keep debating the Hub-and-Spoke model as if the model is the protagonist. It never was.

The protagonist is — and always has been — the maturity of the teams who choose to make it work.